Literature DB >> 18246800

[Expression and biological significance of HPA and HIF-1alpha in human esophageal squamous cell carcinoma].

Jia-Lin Liu1, Bing-Juan Zhou, Ying Zhang, Yan-Ping Wu, Shu-Zhe Liu, Wei-Min G A O, Juan Xue, Wei-Hua Liu.   

Abstract

OBJECTIVE: To investigate the expression of HPA and HIF-1alpha in human esophageal squamous cell carcinoma and their relationship with cancer development, invasion and metastasis.
METHODS: The expression of HPA mRNA and HIF-1alpha protein in 23 mucosa specimens of incisal margin, 26 para-tumorous dysplastic tissues and 70 esophageal squamous cell carcinoma specimens were detected by in situ hybridization assay and immunohistochemical staining, respectively.
RESULTS: The positive expression of HPA mRNA and HIF-1alpha protein were significantly increased as the epithelial cells progressed into carcinoma (P < 0.05). The expression of HPA mRNA and HIF-1alpha protein in the esophageal squamous cell carcinoma were significantly correlated with the invasion depth, lymph node metastasis and clinical staging (P < 0.05), while it was not correlated with the differentiation of tumors (P > 0.05). There was a close correlation between the expression of HPA mRNA and HIF-1alpha protein in the carcinoma tissues (P < 0.01).
CONCLUSION: The high expression of HPA mRNA and HIF-1alpha protein is correlated with carcinogenesis, progression, invasion and metastasis of esophageal squamous cell carcinoma. There may be a positive cooperation between two of them in the carcinogenesis and development of esophageal carcinoma. The determination of HPA mRNA and HIF-1 alpha will be useful in predicting tumor biological behavior.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18246800

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  1 in total

1.  A meta-analysis of HIF-1α and esophageal squamous cell carcinoma (ESCC) risk.

Authors:  Guogui Sun; Wanning Hu; Yifang Lu; Yadi Wang
Journal:  Pathol Oncol Res       Date:  2013-05-09       Impact factor: 3.201

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.